FDA inspection
Avista Pharma Solutions, Inc. dba Cambrex: FDA inspection ending Jan 20, 2005
FDA inspection 362790 · No Action Indicated (NAI) · Agawam, MA
Key facts
| Inspection ID | 362790 |
|---|---|
| Firm | Avista Pharma Solutions, Inc. dba Cambrex |
| FEI number | 1220785 |
| Address | 104 Gold St |
| City | Agawam |
| State | MA |
| ZIP | 01001-3807 |
| Fiscal year | 2005 |
| Inspection end date | Jan 20, 2005 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data